menu
    • menu

    Company profile for Indivior

    NEW Drugs in Dev: 15
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    The world leader in addiction treatment with over 20 years of experience and a patient-focused approach.We at Indivior are on an endeavor – one that is focused on individual patients around the world. Our name reflects this as the key words individual and endeavor harmoniously blend together. It represents and empathizes with the often difficult journey each individual patient takes to overcome the challenges of addiction �...
    The world leader in addiction treatment with over 20 years of experience and a patient-focused approach.We at Indivior are on an endeavor – one that is focused on individual patients around the world. Our name reflects this as the key words individual and endeavor harmoniously blend together. It represents and empathizes with the often difficult journey each individual patient takes to overcome the challenges of addiction – a chronic relapsing disease.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    IndiviorUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Indivior Inc.North Chesterfield, Virginia, USA
    Telephone
    Telephone
    +1 804 379 1090
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.indivior.com/en
    Linkedin
    Linkedin
    https://in.linkedin.com/company/indivior
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/indivior?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    SCOPE Summit

    SCOPE Summit

    Not Confirmed

    envelop Contact Supplier

    SCOPE Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Indivior to Webcast Q4, FY 2025 Financial Results on Feb. 26
    Indivior to Webcast Q4, FY 2025 Financial Results on Feb. 26

    28 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/28/3227443/0/en/Indivior-to-Report-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Host-Webcast-on-February-26%E1%B5%97%CA%B0.html

    GLOBENEWSWIRE
    28 Jan 2026
    Share Share
    Indivior Announces Completion of Redomiciliation to United States
    Indivior Announces Completion of Redomiciliation to United States

    26 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/26/3225493/0/en/Indivior-Announces-Completion-of-Redomiciliation-to-the-United-States.html

    GLOBENEWSWIRE
    26 Jan 2026
    Share Share
    Indivior Unveils 2026 Financial Outlook And Business Update
    Indivior Unveils 2026 Financial Outlook And Business Update

    08 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/08/3215204/0/en/Indivior-Provides-Full-Year-2026-Financial-Guidance-and-Business-Update.html

    GLOBENEWSWIRE
    08 Jan 2026
    Share Share
    Indivior Announces Inclusion In The S&P Smallcap 600 Index
    Indivior Announces Inclusion In The S&P Smallcap 600 Index

    22 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/indivior-announces-inclusion-in-the-sp-smallcap-600-index-302647090.html

    PR NEWSWIRE
    22 Dec 2025
    Share Share
    Study: Extended-Release Buprenorphine Safely Reduces Opioid Use
    Study: Extended-Release Buprenorphine Safely Reduces Opioid Use

    17 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/new-study-shows-extended-release-buprenorphine-safely-delivers-rapid-clinically-meaningful-reductions-in-opioid-use-and-supports-abstinence-in-high-risk-populations-302644924.html

    PR NEWSWIRE
    17 Dec 2025
    Share Share
    Indivior Concludes Legacy U.S. Department Of Justice Matter
    Indivior Concludes Legacy U.S. Department Of Justice Matter

    20 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/indivior-concludes-legacy-us-department-of-justice-matter-302622344.html

    PR NEWSWIRE
    20 Nov 2025
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search